Maïa® trapeziometacarpal joint arthroplasty: Survival and clinical outcomes at 5 years’ follow-up

2019 ◽  
Vol 38 (3) ◽  
pp. 169-173 ◽  
Author(s):  
A. Andrzejewski ◽  
P. Ledoux
Keyword(s):  
Clinical Outcomes ◽  
Joint Arthroplasty ◽  
Trapeziometacarpal Joint

Functional Outcome Following Salvage of Failed Trapeziometacarpal Joint Arthroplasty

2002 ◽  
Vol 27 (1) ◽  
pp. 96-100 ◽  
Author(s):  
K. J. RENFREE ◽  
P. C. DELL
Keyword(s):  
Pain Relief ◽  
Functional Outcome ◽  
Revision Surgery ◽  
Complication Rate ◽  
Joint Arthroplasty ◽  
Pinch Strength ◽  
Subjective Outcome ◽  
Trapeziometacarpal Joint ◽  
Improved Function

The outcomes in 12 patients who underwent revision surgery for a failed trapeziometacarpal joint arthroplasty were assessed. Multiple procedures were common (an average of 4.5 per patient), and associated with an overall complication rate of 27%. However, after an average follow-up of 5 years, nine of the 12 patients reported improved function and ability to complete normal daily tasks. Most patients were satisfied with their level of pain relief, their grip and pinch strength, and their overall final result. The subjective outcome was less satisfactory in those involved in workers’ compensation litigation. All seven attempted scaphoid–thumb metacarpal fusions failed.

Can surgical guidelines minimize complications after Maïa® trapeziometacarpal joint arthroplasty with unconstrained cups?

2017 ◽  
Vol 43 (4) ◽  
pp. 420-425 ◽  
Author(s):  
Pieter Caekebeke ◽  
Joris Duerinckx
Keyword(s):  
Joint Arthroplasty ◽  
Radiological Outcome ◽  
Medium Term ◽  
Trapeziometacarpal Joint ◽  
Level Of Evidence ◽  
Implant Position ◽  
Component Loosening ◽  
Surgical Guidelines ◽  
Cup Position

The most important complications of trapeziometacarpal arthroplasty are dislocation and component loosening. Incorrect cup position is often a contributing factor. Intra-operative guidelines to optimize cup orientation have recently been described. We evaluated the functional and radiological outcome of 50 Maïa® trapeziometacarpal prostheses that were implanted according to these guidelines. The minimum follow-up was 56 months. No constrained cups were used. Functional outcome was good to excellent. No spontaneous dislocations occurred. No radiological signs of loosening were observed. There was one case of premature wear. The survival rate was 96% (95% confidence interval 85 to 99%) at a mean of 65 months, with two prosthesie removed for posttraumatic trapezial fractures. This study shows that correct implant position can lead to reliable medium-term results after trapeziometacarpal joint arthroplasty. Level of evidence: IV

The Effect of the Additional Use of Grommets in Silicone Implant Arthroplasty of the Metacarpophalangeal Joints

1999 ◽  
Vol 24 (5) ◽  
pp. 561-564 ◽  
Author(s):  
K. SCHMIDT ◽  
R. WILLBURGER ◽  
A. OSSOWSKI ◽  
R. K. MIEHLKE
Keyword(s):  
Rheumatoid Arthritis ◽  
Grip Strength ◽  
Clinical Outcomes ◽  
Metacarpophalangeal Joint ◽  
Joint Arthroplasty ◽  
Silicone Implant ◽  
Active Movement ◽  
Ulnar Deviation ◽  
Metacarpophalangeal Joints

After silicone arthroplasty of the metacarpophalangeal (MP) joint there is increasing osteolysis, subsidence and fracture of the implants in the longer postoperative term. In 44 patients with rheumatoid arthritis (54 hands) 151 arthroplasties of the metacarpophalangeal joint were assessed at a mean of 3.9 years postoperatively. In 57 arthroplasties titanium protectors (grommets) were used. There were no significant differences in the clinical outcomes with respect to swelling, correction of ulnar deviation, range of active movement and grip strength. The additional use of grommets in MP joint arthroplasty slightly reduced reactive osteolysis, protected the spacers from breakage and slightly reduced the amount of pain with only a few additional complications in the midterm follow-up.

scholarly journals A radiostereometric and clinical long-term follow-up study of the surface replacement trapeziometacarpal joint prosthesis

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Bart ten Brinke ◽  
Nina M. C. Mathijssen ◽  
Ian F. Blom ◽  
Lennard A. Koster ◽  
Gerald A. Kraan
Keyword(s):  
Clinical Outcomes ◽  
Joint Prosthesis ◽  
Surface Replacement ◽  
Trapeziometacarpal Joint ◽  
Term Survival ◽  
Long Term Survival ◽  
Follow Up Study ◽  
Long Term Follow Up

Abstract Background The aim of this study was to determine long-term survival and clinical outcomes of the surface replacement trapeziometacarpal joint prosthesis (SR™TMC) and to evaluate implant migration using radiostereometric analysis (RSA). Methods In this clinical long-term follow-up study outcomes of ten patients who received the SR™TMC joint prosthesis were evaluated using DASH and Nelson scores, Visual Analogue Scale (VAS) of pain, and key pinch strength. RSA-radiographs were obtained direct postoperatively and 6 months, 1, 5 and 10 years postoperatively and were analyzed using model-based RSA software. Results During follow-up, two early revisions took place. Mean pre-operative DASH and Nelson scores were 54 (SD 15) and 54 (SD 17), improved significantly after 6 months (DASH 25 (SD 20), Nelson 75 (SD 18)) and remained excellent during long-term follow-up in all patients with a stable implant. At final follow-up, clinical scores deteriorated clearly in two patients with a loose implant in situ. Conclusions Long-term survival of the SR™TMC joint prosthesis is relatively poor. However, clinical outcomes improved significantly in the short-term and remained excellent in the long-term in those patients with a stable implant, but deteriorated clearly in case of loosening. The role of RSA in TMC joint arthroplasty is potentially valuable but needs to be further investigated. Several challenges of RSA in the TMC joint have been addressed by the authors and suggestions to optimize RSA-data are given. Trial registration This study was registered in the Netherlands Trial Register (NL7126).

De la Caffinière thumb trapeziometacarpal joint arthroplasty: 16–26 year follow-up

2011 ◽  
Vol 37 (7) ◽  
pp. 621-624 ◽  
Author(s):  
P. Johnston ◽  
A. Getgood ◽  
D. Larson ◽  
A. J. Chojnowski ◽  
A. J. Chakrabarti ◽  
...  
Keyword(s):  
Grip Strength ◽  
Outcome Measures ◽  
Survival Data ◽  
Joint Arthroplasty ◽  
Original Study ◽  
Implant Survival ◽  
Radiographic Outcome ◽  
Trapeziometacarpal Joint ◽  
Outcome Scores

Seventy-one patients (93 implants) had a de la Caffinière prosthesis implanted between 1980 and 1989 and were reviewed and reported in 1997. We reviewed this series 10 years later. Similar outcome measures were used as in the original study, pinch and grip strength measured and validated outcome scores obtained (DASH and EQ-5D). Radiographic outcome was assessed. Twenty-six patients with 39 implants were available for review at a mean of 19 years (range, 16–26 years). Survivorship at 26 years was 73.9% (95% CI, 61.2 to 86.6) for re-operation and 26.0% (95% CI, 0 to 52.7) for all failure. Patients had satisfactory power and thumb mobility and continued to be satisfied without pain. Registries should log such prostheses and add to implant survival data.

Surface replacement trapeziometacarpal joint arthroplasty – early results

2009 ◽  
Vol 34 (6) ◽  
pp. 748-757 ◽  
Author(s):  
A. PENDSE ◽  
A. NISAR ◽  
S. Z. SHAH ◽  
A. BHOSALE ◽  
J. V. FREEMAN ◽  
...  
Keyword(s):  
Joint Arthroplasty ◽  
Dash Score ◽  
Surface Replacement ◽  
Trapeziometacarpal Joint ◽  
Early Results ◽  
Asymptomatic Patients ◽  
The Mean ◽  
Quick Dash ◽  
Tendon Interposition

This study reviews the results of Surface Replacement Trapeziometacarpal (SR TMC, Avanta®, San Diego, CA) total joint arthroplasty. Fifty patients (62 joints) were included in the study. Forty-three patients (54 joints) were seen at final follow up. Seven patients (eight joints) were interviewed over the phone. Seven patients were revised to trapeziectomy and ligament reconstruction with tendon interposition, five for aseptic loosening and two for dislocation. At final follow up, the mean Quick DASH score was 30.4 and the Sollerman Score was 77.3. Radiological review of the surviving 55 joints showed subsidence of four trapezial components in asymptomatic patients. Cumulative survival rate was 91% at 3 years. Eighty-five percent of the patients were satisfied with the outcome of their treatment.

Transarterial embolization of peripheral arteriovenous malformations with ethylenevinyl alcohol copolymer - feasibility, technical outcomes, and clinical outcomes

VASA ◽  
2016 ◽  
Vol 45 (6) ◽  
pp. 497-504 ◽  
Author(s):  
Tom De Beule ◽  
Jan Vranckx ◽  
Peter Verhamme ◽  
Veerle Labarque ◽  
Marie-Anne Morren ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Clinical Improvement ◽  
Arteriovenous Malformations ◽  
Clinical Success ◽  
Transarterial Embolization ◽  
Recurrent Bleeding ◽  
Complete Disappearance ◽  
Ethylene Vinyl Alcohol ◽  
Initial Symptoms

Abstract. Background: The technical and clinical outcomes of catheter-directed embolization for peripheral arteriovenous malformations (AVM) using Onyx® (ethylene-vinyl alcohol copolymer) are not well documented. The purpose of this study was to retrospectively assess the safety, technical outcomes and clinical outcomes of catheter-directed Onyx® embolisation for the treatment of symptomatic peripheral AVMs. Patients and methods: Demographics, (pre-)interventional clinical and radiological data were assessed. Follow-up was based on hospital medical records and telephone calls to the patients’ general practitioners. Radiological success was defined as complete angiographic eradication of the peripheral AVM nidus. Clinical success was defined as major clinical improvement or complete disappearance of the initial symptoms. Results: 25 procedures were performed in 22 patients. The principal indications for treatment were pain (n = 10), limb swelling (n = 6), recurrent bleeding (n = 2), tinnitus (n = 3), and exertional dyspnoea (n = 1). Complete radiological success was obtained in eight patients (36 %); near-complete eradication of the nidus was achieved in the remaining 14 patients. Adjunctive embolic agents were used in nine patients (41 %). Clinical success was observed in 18 patients (82%). Major complications were reported in two patients (9 %). During follow-up, seven patients (32 %) presented with symptom recurrence, which required additional therapy in three patients. Conclusions: Catheter-directed embolisation of peripheral AVMs with Onyx® resulted in major clinical improvement or complete disappearance of symptoms in the vast majority of patients, although complete angiographic exclusion of the AVMs occurred in only a minority of patients.

Conservative Treatment of Vestibular Schwannomas: A Follow-Up Study on Clinical Outcomes

2012 ◽  
Vol 73 (S 02) ◽  
Author(s):  
M. Sadadcharam ◽  
R. Wormald ◽  
M. Javadpour ◽  
D. Rawluk ◽  
R. McConn-Walsh
Keyword(s):  
Conservative Treatment ◽  
Clinical Outcomes ◽  
Vestibular Schwannomas ◽  
Follow Up Study
Sign in / Sign up

Export Citation Format

Share Document